In the biochemical tests, total bilirubin (0.69 vs 0.59/μL, P = .042), AST (51 vs 18 IU/L, P < .001), ALT (76 vs 21 IU/L, P < .001), total cholesterol (199 vs 174 mg/dL P < .001), LDL (116 vs 96 mg/dL, P < .001), and sdLDL levels (12.20 vs 4.25 mg/dL, P < .001) were significantly higher in the NAFLD group. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.